Marks as modifiers of the pten pathway and methods of use

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) A61K 31/7088 (2006.01) A61K 39/395 (2006.01) A61K 45/00 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C12Q 1/00 (2006.01) C12Q 1/02 (2006.01) C12Q 1/48 (2006.01) G01N 33/573 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2528043

Human MARK genes are identified as modulators of the PTEN pathway, and thus are therapeutic targets for disorders associated with defective PTEN function. Methods for identifying modulators of PTEN, comprising screening for agents that modulate the activity of MARK are provided.

L'invention concerne des gènes humains MARK identifiés comme modulateurs de la voie PTEN, et constituant ainsi des cibles thérapeutiques dans les troubles associés à une fonction défectueuse de la PTEN. L'invention concerne également des méthodes d'identification de modulateurs de la PTEN, consistant à cribler des agents modulant l'activité de la MARK.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Marks as modifiers of the pten pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Marks as modifiers of the pten pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Marks as modifiers of the pten pathway and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1919534

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.